Skip to main content
OpenTrials

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

194 public trials 80 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Active, Not Recruiting

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

NCT04521231

Conditions
B Cell Precursor Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University of California San Francisco Fresno at Community Cancer Institute Clovis, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of Illinois Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia

NCT07134088

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • Lucile Packard Childrens Hospital Stanford Palo Alto, California, United States
  • Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • St Jude Childrens Research Hospital Memphis, Tennessee, United States
  • Seattle Childrens Hospital Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Patients Who Achieved Durable Response to Anti-HER2 Treatment

NCT06663787

Conditions
Breast Cancer, Metastatic, Breast Diseases, Breast Neoplasms, +10 more
Locations
  • Natera San Carlos, Texas, United States
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • Nagoya City University Nagoya, Aichi-ken, Japan
  • The Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo, Japan
View Trial Details
Active, Not Recruiting

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

NCT03384914

Conditions
Breast Cancer Female, Breast Cancer Stage I, Breast Cancer Stage II, +16 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory - Winship Cancer Institute Atlanta, Georgia, United States
  • Indiana University - Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details

Related conditions